Soleus Capital Management, L.P. Axogen, Inc. Transaction History
Soleus Capital Management, L.P.
- $1.44 Billion
- Q4 2024
A detailed history of Soleus Capital Management, L.P. transactions in Axogen, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 2,955,943 shares of AXGN stock, worth $57 Million. This represents 3.39% of its overall portfolio holdings.
Number of Shares
2,955,943
Previous 3,005,943
1.66%
Holding current value
$57 Million
Previous $42.1 Million
15.59%
% of portfolio
3.39%
Previous 3.58%
Shares
18 transactions
Others Institutions Holding AXGN
# of Institutions
179Shares Held
36.2MCall Options Held
82.6KPut Options Held
1.1K-
First Light Asset Management, LLC Edina, MN4.51MShares$86.9 Million7.26% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$62.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.43MShares$46.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$46.8 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.25MShares$43.4 Million0.56% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $816M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...